renacort injection
renata limited - hydrocortisone - injection - 100 mg/vial
renacord 30 25mg/ml (30mg/1.2ml) concentrate solution for iv infusion
accord healthcare limited - philippine branch office; distributor: accord healthcare limited - philippine branch office - temsirolimus - concentrate solution for iv infusion - 25mg/ml (30mg/1.2ml)
renalka [renacol is the trade name for export purpose] combination granules
new medical centre trading united arab emirates - 4g sachet x 6 - granules - combination - obstetrics,gynaecology,urinary-tract-genito-urinary disorders
renalka [renacol is the trade name for export purpose]
4g sachet x 6 -
enalagamma hct 20 mg / 12,5 mg tabletten
onsior™ (robenacoxib)
elanco us inc. - robenacoxib (unii: z588009c7c) (robenacoxib - unii:z588009c7c) - robenacoxib 10 mg - onsior should not be used in dogs that have a hypersensitivity to robenacoxib or known intolerance to nsaids.
serenace injection haloperidol 5 mg/ml ampoule 1ml
aspen pharmacare australia pty ltd - haloperidol, quantity: 5 mg/ml - injection, solution - excipient ingredients: water for injections; sodium hydroxide; (s)-lactic acid - chronic therapy: the management of manifestations of psychotic disorders such as schizophrenia, psychosis due to organic brain damage or mental deficiency, the manic phase of manic depressive illness, gilles de la tourette syndrome. short term therapy: the treatment of acute alcoholism for the relief of delusions, hallucinations and confused states, and for the control of accompanying tremulousness and aggressive behaviour. in the treatment of intractable nausea and vomiting associated with radiation or malignancy and not responding to other therapy. neuroleptanalgesia
serenace haloperidol 5.0 mg tablet bottle
aspen pharmacare australia pty ltd - haloperidol, quantity: 5 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; acacia; magnesium stearate; calcium hydrogen phosphate dihydrate; brilliant scarlet 4r - chronic therapy: the management of manifestations of psychotic disorders such as schizophrenia, psychosis due to organic brain damage or mental deficiency, the manic phase of manic depressive illness, gilles de la tourette syndrome. short term therapy: the treatment of acute alcoholism for the relief of delusions, hallucinations and confused states, and for the control of accompanying tremulousness and aggressive behaviour. in the treatment of intractable nausea and vomiting associated with radiation or malignancy and not responding to other therapy. neuroleptanalgesia
serenace haloperidol 0.5 mg tablet bottle
aspen pharmacare australia pty ltd - haloperidol, quantity: 0.5 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; acacia; magnesium stearate; quinoline yellow; calcium hydrogen phosphate dihydrate; green s - chronic therapy: the management of manifestations of psychotic disorders such as schizophrenia, psychosis due to organic brain damage or mental deficiency, the manic phase of manic depressive illness, gilles de la tourette syndrome. short term therapy: the treatment of acute alcoholism for the relief of delusions, hallucinations and confused states, and for the control of accompanying tremulousness and aggressive behaviour. in the treatment of intractable nausea and vomiting associated with radiation or malignancy and not responding to other therapy. neuroleptanalgesia
serenace haloperidol 1.5 mg tablet bottle
aspen pharmacare australia pty ltd - haloperidol, quantity: 1.5 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; acacia; magnesium stearate; calcium hydrogen phosphate dihydrate - chronic therapy: the management of manifestations of psychotic disorders such as schizophrenia, psychosis due to organic brain damage or mental deficiency, the manic phase of manic depressive illness, gilles de la tourette syndrome. short term therapy: the treatment of acute alcoholism for the relief of delusions, hallucinations and confused states, and for the control of accompanying tremulousness and aggressive behaviour. in the treatment of intractable nausea and vomiting associated with radiation or malignancy and not responding to other therapy. neuroleptanalgesia